The Journal of Neuroscience, February 15, 2000, 20(4):1318-1323
Nicotine Enhances the Biosynthesis and Secretion of Transthyretin
from the Choroid Plexus in Rats: Implications for
-Amyloid
Formation
Ming D.
Li1,
Justin K.
Kane1,
Shannon G.
Matta1,
William S.
Blaner2, and
Burt M.
Sharp1
1 Department of Pharmacology, University of Tennessee
College of Medicine, Memphis, Tennessee 38163, and
2 Institute of Human Nutrition, Columbia University, New
York, New York 10032
Epidemiological studies indicated that cigarette smoking protects
against the development of several neurodegenerative disorders, including Alzheimer's disease (AD). However, the molecular
mechanism(s) underlying this is poorly understood. To gain insight into
these protective effects, we used differential display PCR
(DD-PCR) to amplify RNA from various brain regions of rats
self-administering (SA) nicotine compared with yoked-saline controls.
We found that the transthyretin (TTR) gene, whose product has been
shown to bind to amyloid
(A
) protein and prevent A
aggregation, was more abundantly expressed (~1.5- to 2.0-fold) in the
brainstem and hippocampus (areas containing choroid plexus) of nicotine SA rats. Subsequently, quantitative reverse transcription-PCR analysis confirmed these DD-PCR findings and demonstrated that nicotine
increased TTR mRNA levels in these regions in a time- and
dose-dependent manner. Significantly higher TTR protein concentrations were also detected in the ventricular CSF of nicotine-treated rats. In contrast, no differences either in plasma TTR or in CSF and
plasma retinol-binding protein were detected.
Immunohistochemical analysis showed that immunoreactive TTR was 41.5%
lower in the choroid plexus of nicotine-treated rats compared with the
saline controls. On the basis of these data, we speculate that the
protective effects of nicotine on the development of AD may be
attributable, in part, to the increased biosynthesis and secretion of
TTR from the choroid plexus. These findings also point toward new
approaches that may take advantage of the potentially novel therapeutic
effects of nicotinic agonists in patients with AD.
Key words:
nicotine; transthyretin;
-amyloid; Alzheimer's
disease; choroid plexus; differential display PCR
Copyright © 2000 Society for Neuroscience 0270-6474/00/2041318-06$05.00/0